MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$23,665K
Free Cash flow
-$75,734K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from sales and maturiti...
Prepaid expenses and other curre...
Research and development incenti...
Others
Negative Cash Flow Breakdown
Accrued expenses and other curre...
Purchase of short-term investmen...
Accounts payable
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-69,766
-73,217
-70,930
-83,100
Stock-based compensation expense
7,674
8,125
7,047
8,338
Depreciation and amortization
937
769
848
842
Operating lease, right-of-use-asset amortization
206
201
194
191
Finance lease, right-of-use-asset amortization
607
607
607
607
Net amortization of premiums and discounts on short-term investments
112
313
134
759
Impairment on property, plant and equipment
108
188
-
-
Noncash interest expense
806
679
425
414
Unrealized foreign currency transaction (gains) losses
688
77
581
875
Research and development incentives receivable
-1,347
464
349
367
Prepaid expenses and other current assets
-3,129
362
-36
140
Other non-current assets
-
0
0
-
Accounts payable
-2,334
956
-730
-8,930
Accrued expenses and other current liabilities
-17,424
6,863
-1,913
2,770
Operating lease liabilities
-218
-213
-207
-203
Other non-current liabilities
0
97
-268
0
Net cash used in operating activities
-75,728
-56,161
-65,955
-81,212
Purchases of property, plant and equipment and software capitalization
6
5
135
1,343
Purchase of short-term investments
9,884
3,953
26,511
9,849
Proceeds from sales and maturities of short-term investments
59,883
90,464
101,766
95,361
Net cash provided by investing activities
49,993
86,506
75,120
84,169
Proceeds from issuance of common stock, net of fees and offering costs
-
-
-
0
Proceeds from issuance of common stock, net of offering costs-Common Stock
-
0
0
-
Proceeds from issuance of prefunded warrants to purchase common stock, net of underwriting fees and offering costs
-
0
0
0
Proceeds from issuance of common stock, net of offering costs-ATMOffering
-
20,783
10,364
-
Proceeds from long-term debt
-
35,000
-
-
Principal payment of finance lease obligation
203
198
195
177
Proceeds from exercise of stock options
1,003
92
282
501
Net cash provided by (used in) financing activities
800
55,677
10,451
324
Effect of exchange rate changes on cash, cash equivalents and restricted cash
1,270
50
1,036
1,642
Net decrease in cash, cash equivalents and restricted cash
-23,665
86,072
20,652
4,923
Cash, cash equivalents and restricted cash at beginning of period
210,727
104,003
104,003
112,822
Cash, cash equivalents and restricted cash at end of period
187,062
210,727
124,655
104,003
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from sales and
maturities of short-term...
$59,883K
(-43.17%↓ Y/Y)
Proceeds from exercise of
stock options
$1,003K
(12437.50%↑ Y/Y)
Net cash provided by
investing activities
$49,993K
(-23.14%↓ Y/Y)
Effect of exchange rate
changes on cash, cash...
$1,270K
(178.59%↑ Y/Y)
Net cash provided by
(used in) financing...
$800K
(606.33%↑ Y/Y)
Canceled cashflow
$9,890K
Canceled cashflow
$203K
Net decrease in
cash, cash...
-$23,665K
(-72.21%↓ Y/Y)
Canceled cashflow
$52,063K
Stock-based compensation
expense
$7,674K
(-12.42%↓ Y/Y)
Prepaid expenses and
other current assets
-$3,129K
(-1237.18%↓ Y/Y)
Research and development
incentives receivable
-$1,347K
(17.41%↑ Y/Y)
Depreciation and
amortization
$937K
(7.33%↑ Y/Y)
Noncash interest
expense
$806K
(94.22%↑ Y/Y)
Finance lease,
right-of-use-asset amortization
$607K
(0.00%↑ Y/Y)
Operating lease,
right-of-use-asset amortization
$206K
(11.35%↑ Y/Y)
Impairment on property,
plant and equipment
$108K
Purchase of short-term
investments
$9,884K
(-73.70%↓ Y/Y)
Purchases of property,
plant and equipment...
$6K
(-99.78%↓ Y/Y)
Principal payment of
finance lease...
$203K
(22.29%↑ Y/Y)
Net cash used in
operating activities
-$75,728K
(1.67%↑ Y/Y)
Canceled cashflow
$14,814K
Net loss
-$69,766K
(19.53%↑ Y/Y)
Accrued expenses and
other current...
-$17,424K
(-214.74%↓ Y/Y)
Accounts payable
-$2,334K
(-161.99%↓ Y/Y)
Unrealized foreign
currency transaction...
$688K
(216.41%↑ Y/Y)
Operating lease
liabilities
-$218K
(-11.79%↓ Y/Y)
Net amortization of
premiums and discounts on...
$112K
(-91.64%↓ Y/Y)
Buy us a coffee
Replimune Group, Inc. (REPL)
Replimune Group, Inc. (REPL)